AIM: To calculate cost effectiveness of the treatment of critically ill patients in a medical intensive care unit (ICU) of a middle income country with limited access to ICU resources. METHODS: A prospective cohort study and economic evaluation of consecutive patients treated in a recently established medical ICU in Sarajevo, Bosnia and Herzegovina. A cost utility analysis of the intensive care of critically ill patients compared to the hospital ward treatment from the perspective of the health care system was subsequently performed. Incremental cost effectiveness was calculated using estimates of ICU vs non-ICU treatment effectiveness based on a formal systematic review of published studies. Decision analytic modeling was used to compare treatment alternatives. Sensitivity analyses of the key model parameters were performed. RESULTS: Out of 148 patients, seventy patients (47.2%) survived to one year after critical illness with a median quality of life index 0.64 [interquartile range(IQR) 0.49-0.76]. Median number of life years gained per patient was 30 (IQR 16-40) or 18 quality adjusted life years (QALYs) (IQR 7-28). The cost of treatment of critically ill patients varied between 1820 dollar and 20109 dollar per hospital survivor and between 100 dollar and 2514 dollar per QALY saved. Mean factors that influenced costs were: Age, diagnostic category, ICU and hospital length of stay and number and type of diagnostic and therapeutic interventions. The incremental cost effectiveness ratio for ICU treatment was estimated at 3254 dollar per QALY corresponding to 35% of per capita GDP or a Very Cost Effective category according to World Health Organization criteria. CONCLUSION: The ICU treatment of critically ill medical patients in a resource poor country is cost effective and compares favorably with other medical interventions. Public health authorities in low and middle income countries should encourage development of critical care services.
AIM: To calculate cost effectiveness of the treatment of critically ill patients in a medical intensive care unit (ICU) of a middle income country with limited access to ICU resources. METHODS: A prospective cohort study and economic evaluation of consecutive patients treated in a recently established medical ICU in Sarajevo, Bosnia and Herzegovina. A cost utility analysis of the intensive care of critically ill patients compared to the hospital ward treatment from the perspective of the health care system was subsequently performed. Incremental cost effectiveness was calculated using estimates of ICU vs non-ICU treatment effectiveness based on a formal systematic review of published studies. Decision analytic modeling was used to compare treatment alternatives. Sensitivity analyses of the key model parameters were performed. RESULTS: Out of 148 patients, seventy patients (47.2%) survived to one year after critical illness with a median quality of life index 0.64 [interquartile range(IQR) 0.49-0.76]. Median number of life years gained per patient was 30 (IQR 16-40) or 18 quality adjusted life years (QALYs) (IQR 7-28). The cost of treatment of critically ill patients varied between 1820 dollar and 20109 dollar per hospital survivor and between 100 dollar and 2514 dollar per QALY saved. Mean factors that influenced costs were: Age, diagnostic category, ICU and hospital length of stay and number and type of diagnostic and therapeutic interventions. The incremental cost effectiveness ratio for ICU treatment was estimated at 3254 dollar per QALY corresponding to 35% of per capita GDP or a Very Cost Effective category according to World Health Organization criteria. CONCLUSION: The ICU treatment of critically ill medical patients in a resource poor country is cost effective and compares favorably with other medical interventions. Public health authorities in low and middle income countries should encourage development of critical care services.
Entities:
Keywords:
Cost benefit analysis; Decision analysis; Economics; Intensive care; Intensive care unit; Mortality; Quality of life
Authors: Elisheva Simchen; Charles L Sprung; Noya Galai; Yana Zitser-Gurevich; Yaron Bar-Lavi; Leon Levi; Fabio Zveibil; Micha Mandel; George Mnatzaganian; Nethanel Goldschmidt; Anat Ekka-Zohar; Inbal Weiss-Salz Journal: Crit Care Med Date: 2007-02 Impact factor: 7.598
Authors: Philipp Kümpers; Carsten Hafer; Alexander Lukasz; Ralf Lichtinghagen; Korbinian Brand; Danilo Fliser; Robert Faulhaber-Walter; Jan T Kielstein Journal: Crit Care Date: 2010-02-01 Impact factor: 9.097
Authors: B Delannoy; B Floccard; F Thiolliere; M Kaaki; M Badet; S Rosselli; C E Ber; A Saez; G Flandreau; Claude Guérin Journal: Intensive Care Med Date: 2009-08-20 Impact factor: 17.440
Authors: Marcus J Schultz; Martin W Dunser; Arjen M Dondorp; Neill K J Adhikari; Shivakumar Iyer; Arthur Kwizera; Yoel Lubell; Alfred Papali; Luigi Pisani; Beth D Riviello; Derek C Angus; Luciano C Azevedo; Tim Baker; Janet V Diaz; Emir Festic; Rashan Haniffa; Randeep Jawa; Shevin T Jacob; Niranjan Kissoon; Rakesh Lodha; Ignacio Martin-Loeches; Ganbold Lundeg; David Misango; Mervyn Mer; Sanjib Mohanty; Srinivas Murthy; Ndidiamaka Musa; Jane Nakibuuka; Ary Serpa Neto; Mai Nguyen Thi Hoang; Binh Nguyen Thien; Rajyabardhan Pattnaik; Jason Phua; Jacobus Preller; Pedro Povoa; Suchitra Ranjit; Daniel Talmor; Jonarthan Thevanayagam; C Louise Thwaites Journal: Intensive Care Med Date: 2017-03-27 Impact factor: 17.440
Authors: Amelie O von Saint André-von Arnim; Jonah Attebery; Teresa Bleakly Kortz; Niranjan Kissoon; Elizabeth M Molyneux; Ndidiamaka L Musa; Katie R Nielsen; Ericka L Fink Journal: Front Pediatr Date: 2017-12-22 Impact factor: 3.418
Authors: Janet V Diaz; Elisabeth D Riviello; Alfred Papali; Neill K J Adhikari; Juliana C Ferreira Journal: Ann Glob Health Date: 2019-01-22 Impact factor: 2.462
Authors: Lia I Losonczy; Alfred Papali; Sean Kivlehan; Emilie J Calvello Hynes; Georgina Calderon; Adam Laytin; Vanessa Moll; Ahmed Al Hazmi; Mohammed Alsabri; Diptesh Aryal; Vincent Atua; Torben Becker; Nicole Benzoni; Enrico Dippenaar; Edrist Duneant; Biruk Girma; Naomi George; Preeti Gupta; Michael Jaung; Bonaventure Hollong; Diulu Kabongo; Rebecca J Kruisselbrink; Dennis Lee; Augusto Maldonado; Jesse May; Maxwell Osei-Ampofo; Yasein Omer Osman; Christian Owoo; Shada A Rouhani; Hendry Sawe; Daniel Schnorr; Gentle S Shrestha; Aparajita Sohoni; Menbeu Sultan; Andrea G Tenner; Hanan Yusuf; Neill K Adhikari; Srinvas Murthy; Niranjan Kissoon; John Marshall; Abdo Khoury; Abdelouahab Bellou; Lee Wallis; Teri Reynolds Journal: Ann Glob Health Date: 2021-11-03 Impact factor: 2.462
Authors: Qalab Abbas; Adrian Holloway; Paula Caporal; Eliana López-Barón; Asya Agulnik; Kenneth E Remy; John A Appiah; Jonah Attebery; Ericka L Fink; Jan Hau Lee; Shubhada Hooli; Niranjan Kissoon; Erika Miller; Srinivas Murthy; Fiona Muttalib; Katie Nielsen; Maria Puerto-Torres; Karla Rodrigues; Firas Sakaan; Adriana Teixeira Rodrigues; Erica A Tabor; Amelie von Saint Andre-von Arnim; Matthew O Wiens; William Blackwelder; David He; Teresa B Kortz; Adnan T Bhutta Journal: Front Pediatr Date: 2022-01-28 Impact factor: 3.418
Authors: Claudia Marotta; Francesco Di Gennaro; Luigi Pisani; Vincenzo Pisani; Josephine Senesie; Sarjoh Bah; Michael M Koroma; Claudia Caracciolo; Giovanni Putoto; Fabio Amatucci; Elio Borgonovi Journal: Ann Glob Health Date: 2020-07-20 Impact factor: 2.462